Startseite Naturwissenschaften 4. SFC applications for active pharmaceutical ingredient analysis
Kapitel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

4. SFC applications for active pharmaceutical ingredient analysis

  • Lu Zeng und Paddi Ekhlassi
Veröffentlichen auch Sie bei De Gruyter Brill
Supercritical Fluid Chromatography
Ein Kapitel aus dem Buch Supercritical Fluid Chromatography

Abstract

This chapter focuses on utilizing supercritical fluid chromatography (SFC) and its applications in drug development for the analysis of active pharmaceutical ingredient (API) in the manufacturing process. Various screening approaches such as sequential, parallel or tandem column chromatography offers a unique and useful tool for separations of impurities and optimizing the overall selectivity. With the new age of technology, modern SFC instruments can be qualified and chiral and achiral SFC methods can be validated for the GMP API release and/or cleaning testing under the regulatory guidelines. Thus, given the advantageous proprieties of CO2-based mobile phase and low consumption of solvents, we believe that this technology has become an equally valuable primary option for method development and validation in pharmaceutical industry analytical laboratories.

Abstract

This chapter focuses on utilizing supercritical fluid chromatography (SFC) and its applications in drug development for the analysis of active pharmaceutical ingredient (API) in the manufacturing process. Various screening approaches such as sequential, parallel or tandem column chromatography offers a unique and useful tool for separations of impurities and optimizing the overall selectivity. With the new age of technology, modern SFC instruments can be qualified and chiral and achiral SFC methods can be validated for the GMP API release and/or cleaning testing under the regulatory guidelines. Thus, given the advantageous proprieties of CO2-based mobile phase and low consumption of solvents, we believe that this technology has become an equally valuable primary option for method development and validation in pharmaceutical industry analytical laboratories.

Heruntergeladen am 3.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/9783110618983-004/html
Button zum nach oben scrollen